KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Receivables (2016 - 2025)

Vertex Pharmaceuticals has reported Change in Receivables over the past 17 years, most recently at $99.4 million for Q4 2025.

  • Quarterly results put Change in Receivables at $99.4 million for Q4 2025, up 244.06% from a year ago — trailing twelve months through Dec 2025 was $347.3 million (up 249.75% YoY), and the annual figure for FY2025 was $347.3 million, up 249.75%.
  • Change in Receivables for Q4 2025 was $99.4 million at Vertex Pharmaceuticals, up from $59.9 million in the prior quarter.
  • Over the last five years, Change in Receivables for VRTX hit a ceiling of $251.6 million in Q1 2024 and a floor of -$135.1 million in Q2 2024.
  • Median Change in Receivables over the past 5 years was $55.8 million (2024), compared with a mean of $58.2 million.
  • Biggest five-year swings in Change in Receivables: skyrocketed 1531.11% in 2021 and later tumbled 4758.62% in 2024.
  • Vertex Pharmaceuticals' Change in Receivables stood at $43.5 million in 2021, then tumbled by 123.45% to -$10.2 million in 2022, then plummeted by 50.98% to -$15.4 million in 2023, then crashed by 348.05% to -$69.0 million in 2024, then skyrocketed by 244.06% to $99.4 million in 2025.
  • The last three reported values for Change in Receivables were $99.4 million (Q4 2025), $59.9 million (Q3 2025), and $18.4 million (Q2 2025) per Business Quant data.